Table 1.
Patient demographics and treatments.
| All patients (n = 240) | Biologic patients (n = 80) | Nonbiologic patients (n = 160) | |
|---|---|---|---|
| Mean age, years (range) | 58.6 (15–85) | 55.4 (15–82) | 60.2 (23–85) |
| Female (%) | 70 | 75 | 68 |
| Receiving a steroid at last consultation (%) | 51.7 | 51.3 | 51.9 |
| Receiving a DMARD at last consultation (%) | 92.1 | 83.8 | 96.3 |
| Number of DMARDs prescribed (%) | |||
| Zero | 7.9 | 16.3 | 3.8 |
| One | 56.3 | 66.3 | 51.3 |
| Two | 29.2 | 15.0 | 36.3 |
| Three | 6.7 | 2.5 | 8.8 |
| Type of DMARD (%) | |||
| Methotrexate | 79.2 | 75.0 | 81.3 |
| Leflunomide | 29.6 | 13.8 | 37.5 |
| Hydroxychloroquine | 13.8 | 8.8 | 16.3 |
| Sulfasalazine | 9.2 | 5.0 | 11.3 |
| Other (azathioprine, 6mercaptopurine, cyclosporine) | 2.9 | 1.3 | 3.8 |